Impetigo is primarily caused by bacteria such as Staphylococcus aureus and Streptococcus pyogenes, and while some strains, particularly methicillin-resistant Staphylococcus aureus (MRSA), can exhibit multidrug resistance, most cases of impetigo are treatable with standard antibiotics. However, the emergence of resistant strains can complicate treatment. It's important for healthcare providers to consider local resistance patterns when prescribing antibiotics for impetigo. Overall, while multidrug-resistant cases can occur, they are not the norm for this condition.
The emergence of dapsone-resistant strains of leprosy prompted the introduction of multidrug therapy.
Robert B. Giffin has written: 'Addressing the threat of drug-resistant tuberculosis' -- subject(s): Antitubercular agents, Antitubercular Agents, Drug resistance, Transmission, Multidrug-resistant tuberculosis, Internationality, Complications, Tuberculosis, Tuberculosis, Multidrug-Resistant, Congresses, HIV Infections
The multidrug resistant pumps in bacterial cell membranes can cause resistance to multiple antibiotics by actively pumping them out of the cell, reducing the effectiveness of antibiotic treatment. This can make infections more difficult to treat and lead to the development of superbugs that are not easily killed by antibiotics.
It means that multiple drugs that are commonly used to treat it no longer work. So it means the "bug" is a "superbug" and harder to treat.
when was Impetigo discovered
Impetigo :)
Yes, impetigo is spreadable.
Have no fear, Impetigo is here!! Retapamulin is a common impetigo drug.
"Rule out impetigo" means make sure it's not impetigo, a bacterial infection of the skin.
Presently, there is no vaccine for Impetigo.
Kevin J. Brooks has written: 'Tuberculosis threat' -- subject(s): Epidemilogy, Epidemiology, International Cooperation, International cooperation, Tuberculosis, Tuberculosis, Multidrug-Resistant, Prevention & control, Prevention
Impetigo - 1983 was released on: USA: 1983